Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,

Slides:



Advertisements
Similar presentations
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
Advertisements

High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T Cells  Faith M. Young, Andrew.
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand  Yuji Miura, Christopher.
Depletion of Naïve Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor.
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Secondary Lymphoid Organs Contribute to, but Are Not Required for the Induction of Graft-versus-Host Responses following Allogeneic Bone Marrow Transplantation:
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation 
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
Extracorporeal Photopheresis Attenuates Murine Graft-versus-Host Disease via Bone Marrow–Derived Interleukin-10 and Preserves Responses to Dendritic Cell.
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
by Dennis Adeegbe, Robert B. Levy, and Thomas R. Malek
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft- versus-host disease  Christopher J Thoburn, Yuji Miura, Emilie C Bright,
Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft- versus-Host Disease in a Murine Model of Allogeneic Hematopoietic.
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome  Gerhard C. Hildebrandt, Krystyna.
Allan D. Hess  Biology of Blood and Marrow Transplantation 
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takero Shindo, Takayuki.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Volume 42, Issue 5, Pages (May 2015)
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.
Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without.
Minor Antigen Distribution Predicts Site-Specific Graft-versus-Tumor Activity of Adoptively Transferred, Minor Antigen-Specific CD8 T Cells  Jessica C.
Adoptive Therapy with T Cells/NK Cells
Increase of Intermediate Monocytes in Graft-versus-Host Disease: Correlation with MDR1+Th17.1 Levels and the Effect of Prednisolone and 1α,25-Dihydroxyvitamin.
The Effects of Interleukin 10 and Interferon γ Cytokine Gene Polymorphisms on Survival after Autologous Bone Marrow Transplantation for Patients with.
Volume 18, Issue 5, Pages (May 2003)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Volume 140, Issue 7, Pages (June 2011)
Xinchun Chen, Yi Zeng, Gang Li, Nicolas Larmonier, Michael W
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation  Jeffery J. Auletta,
Deficiency of MyD88 Signaling in CD4 Tconvs Increases Tregs Suppression through Loss of ST2 Signaling, Reducing Acute Graft-Versus-Host Disease in Multiple.
Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune Response  Andrea T. Badillo, Kirstin J. Beggs, Elisabeth.
Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells 
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
The Expression of Th17-Associated Cytokines in Human Acute Graft-versus-Host Disease  Yuejun Liu, Yifeng Cai, Lan Dai, Guanghua Chen, Xiao Ma, Ying Wang,
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen- Specific Tolerance That Can Prevent GVHD Lethality In Vivo  Matthew.
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
B7.2−/− Mature Dendritic Cells Generate T-Helper 2 and Regulatory T Donor Cells in Fetal Mice after In Utero Allogeneic Bone Marrow Transplantation  Swati.
Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous- BMT Improves the Survival of Leukemia-Challenged Mice  Jenny Zilberberg,
Volume 29, Issue 6, Pages (December 2008)
Volume 27, Issue 3, Pages (September 2007)
Shelley Gorman, Melinda A. Judge, Prue H. Hart 
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 34, Issue 3, Pages (March 2011)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Raimon Duran-Struuck, Isao Tawara, Kathi Lowler, Shawn G
Volume 126, Issue 6, Pages (September 2006)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: Epitope association rate  Guillaume Roy-Proulx, Chantal Baron, Claude Perreault 
Volume 28, Issue 5, Pages (May 2008)
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo by Holger Hackstein, Timucin Taner,
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess, Christopher J. Thoburn  Biology of Blood and Marrow Transplantation  Volume 12, Issue 5, Pages 518-529 (May 2006) DOI: 10.1016/j.bbmt.2006.01.007 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Suppression of adoptive transfer of syngeneic GVHD. Splenic T cells were harvested from animals after resolution of syngeneic GVHD or from normal animals after intravenous challenge with 60 × 106 effector T cells. Regulatory population was depleted of CD4+, CD8+, or CD25+ cells with immunomagnetic beads. Graded numbers of regulatory cells were adoptively transferred into secondary recipients (n = 6-8) along with 30 × 106 effector T cells harvested from animals with acute syngeneic GVHD (7-10 days after initial onset). Recipients were examined daily for 6 weeks for development of syngeneic GVHD. Presence or absence of syngeneic GVHD was confirmed by biopsy. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Suppression of in vitro cytokine response of autoreactive effector cells to CLIP. Splenic T cells were harvested from normal animals after intravenous challenge with 60 × 106 effector T cells. Regulatory population was depleted of CD4+, CD8+, or CD25+ cells with immunomagnetic beads. Regulatory T cells (1 × 105) were irradiated (1250R) and incubated with equal number of autoreactive T cells harvested from animals with syngeneic GVHD. Cells were stimulated with syngeneic APCs (1 × 104) loaded with CLIP. After 48 hours of incubation, cells were harvested and assessed for levels of IL-2 and IFNγ mRNA transcripts by quantitative PCR. IFNγ and IL-2 mRNA transcripts were not detected in control cultures of irradiated regulatory cells cultured with peptide-loaded APCs. Data were standardized against mRNA transcript levels for housekeeping gene, GAPDH. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Ex vivo analysis of cytokine mRNA transcripts in CLIP-reactive CD4+CD25+ T-cell subsets. N-CLIP- and CLIP-C-reactive CD4+CD25+ T cells were isolated flow cytometrically from spleens of normal animals, animals with syngeneic GVHD, and animals after resolution of disease. Cells were assessed for cytokine (IL-2, IL-4, IL-10, and IFNγ) mRNA transcripts by quantitative PCR. Data were standardized against mRNA transcript levels for housekeeping gene, GAPDH. ND = Not detected. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Foxp3 Expression in CLIP-reactive CD4+CD25+ T-cell subsets. N-CLIP- and CLIP-C-reactive CD4+CD25+ T cells were isolated flow cytometrically from normal animals, animals with syngeneic GVHD, and animals after resolution of disease. Foxp3 mRNA transcript levels were assessed by quantitative PCR. Data were standardized against GAPD mRNA transcript levels. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Regulation of in vitro cytokine tesponse by N-CLIP- and CLIP-C-reactive T-cell subsets. N-CLIP- and CLIP-C-reactive T cells were isolated flow cytometrically from animals after resolution of syngeneic GVHD. In addition, CLIP-reactive T-cell subsets were depleted of cells expressing CD4, CD8, or CD25 with immunomagnetic beads. Cells (1 × 105) were extensively washed and assessed for their ability to suppress in vitro response of syngeneic GVHD effector lymphocytes (1 × 105) stimulated with CLIP presented by syngeneic APCs (1 × 104). After 48 hours of culture, cells were harvested assessed for levels of IL-2 and IFNγ mRNA transcripts by quantitative PCR. IFNγ and IL-2 mRNA transcripts were not detected in control cultures of irradiated regulatory cells and peptide-loaded APCs. Data were standardized against mRNA transcript levels for housekeeping gene, GAPDH. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 Regulatory activity after peptide immunization. Normal Lewis rats were immunized intradermally with syngeneic APCs loaded with either N-CLIP or CLIP-C. Fourteen days later, splenic T cells (1 × 105) were harvested and cocultured with equal number of syngeneic GVHD effector T cells. Spleen cells were stimulated with syngeneic APCs (1 × 104) loaded with CLIP. After 48 hours of culture, cells were harvested assessed for levels of IL-2 and IFNγ mRNA transcripts by quantitative PCR. Data were standardized against mRNA transcript levels for housekeeping gene, GAPDH. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 7 Response of CD4+CD25+ T cells after immunization with N-CLIP and CLIP-C peptides. Normal Lewis rats were immunized intradermally with N-CLIP and CLIP-C peptides presented by syngeneic APCs. Fourteen days later, CD4+CD25+ Tcells (1 × 105) were stimulated in vitro with syngeneic APCs (1 × 104) loaded with either N-CLIP or CLIP-C peptide variant. After 48 hours of culture, the cells were harvested assessed for cytokine and Foxp3 mRNA transcript levels by quantitative PCR. Data were standardized against mRNA transcript levels for housekeeping gene, GAPDH. These results are representative of 3 separate experiments. Biology of Blood and Marrow Transplantation 2006 12, 518-529DOI: (10.1016/j.bbmt.2006.01.007) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions